Deadline Approaching: Cytokinetics, Incorporated (CYTK) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Group 1 - The article highlights the upcoming deadline of November 17, 2025, for investors to file a lead plaintiff motion in a case related to Cytokinetics, Incorporated [1] - The case is on behalf of investors who purchased Cytokinetics common stock during the class period from December 27, 2023, to May 6, 2025 [1] - Investors who suffered losses in Cytokinetics are encouraged to contact the Law Offices of Howard G. Smith for assistance [1]